Novel Model of Integrated Care of Older Patients With Atrial Fibrillation and Heart Failure in Rural China (MIRACLE-AFHF)
1 other identifier
interventional
942
1 country
3
Brief Summary
This cluster randomization study aims to compare village-doctor led integrated care versus usual care to improve heart failure risk management, guideline-directed medical therapy, self-management adherence, and clinical outcomes for older patients with atrial fibrillation and heart failure in rural China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable atrial-fibrillation
Started Aug 2026
Typical duration for not_applicable atrial-fibrillation
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2026
CompletedFirst Posted
Study publicly available on registry
March 25, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2029
Study Completion
Last participant's last visit for all outcomes
December 30, 2029
July 28, 2026
June 1, 2026
3.4 years
March 16, 2026
July 25, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Change in MAGGIC Heart Failure Risk Score
A heart failure prognostic model integrating 13 key predictors, including age, LVEF, systolic blood pressure, BMI, serum creatinine, NYHA functional class, and medication status.
Baseline to 12 months
Composite Cardiovascular Endpoint
Composite cardiovascular endpoint, including cardiovascular death, ischemic or hemorrhagic stroke, hospitalization for worsening heart failure or acute coronary syndrome, and emergency visits due to atrial fibrillation.
36 months after baseline
Secondary Outcomes (16)
Cardiovascular Death
12 months after baseline
Cardiovascular Hospitalization
12 months after baseline
Emergency Visit for Cardiovascular Events
12 months after baseline
ischemic or hemorrhagic Stroke
12 months after baseline
The proportion of patients who met all the three criteria for the ABC pathway of integrated AF care
12 month after baseline
- +11 more secondary outcomes
Study Arms (2)
Intervention Group
EXPERIMENTALParticipants in this arm will receive village-doctor led integrated care for atrial fibrillation and heart failure. Village doctors will receive standardized training based on the AF ABC pathway and heart failure GDMT principles. Patients will receive structured self-management education focused on medication adherence, symptom monitoring, lifestyle modification, and recognition of warning signs.
Control Group
ACTIVE COMPARATORParticipants in this arm will receive usual chronic disease management according to the National Basic Public Health Service requirements.
Interventions
1. Village doctors will conduct monthly follow-up, including clinical assessment, vital-sign monitoring, medication review, risk screening, health education, and referral when needed. 2. For patients with clinical deterioration or treatment difficulties, village doctors may use a remote care platform to obtain specialist consultation and individualized recommendations. 3. Village doctors will receive standardized training based on the AF ABC pathway and heart failure GDMT principles. 4. Patients will receive structured education on medication adherence, symptom monitoring, lifestyle modification, and recognition of warning signs.
Usual care includes routine follow-up, general health education, medication registration, and standard referral procedures provided by local primary care providers. Participants will not receive the structured village-doctor led integrated care program.
Eligibility Criteria
You may not qualify if:
- Expected life expectancy of less than 12 months.
- Severe renal insufficiency (Ccr \< 30ml/min) or ongoing dialysis treatment.
- Cardiac insufficiency secondary to correctable causes, including hyperthyroid heart disease, anemic heart disease, or uncorrected congenital heart disease.
- Indications for pacemaker implantation without having undergone implantation.
- Chronic obstructive pulmonary disease (COPD) complicated by type II respiratory failure.
- Special populations, including patients with mental illnesses.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Village Clinics in Dongtai City, Jiangsu Province
Yancheng, Dongtai, 224200, China
Village Clinics in Jiangdu District, Jiangsu Province
Yangzhou, Jiangdu, 225267, China
Village Clinics in Suining County, Jiangsu Province
Xuzhou, Suining, 221200, China
Related Publications (3)
Li M, Chu M, Shen Y, Zhang S, Yin X, Yang S, Lip GYH, Chen M; MIRACLE-AF Trial Investigators. A Novel Model of Integrated Care of Older Patients With Atrial Fibrillation in Rural China. JACC Asia. 2024 Jul 30;4(10):764-773. doi: 10.1016/j.jacasi.2024.07.006. eCollection 2024 Oct.
PMID: 39553909BACKGROUNDChu M, Zhang S, Gong J, Yang S, Yang G, Sun X, Wu D, Xia Y, Jiao J, Peng X, Peng Z, Hong L, Wang Z, Li M, Lip GYH, Chen M; MIRACLE-AF Investigators. Telemedicine-based integrated management of atrial fibrillation in village clinics: a cluster randomized trial. Nat Med. 2025 Apr;31(4):1276-1285. doi: 10.1038/s41591-025-03511-2. Epub 2025 Feb 21.
PMID: 39984634BACKGROUNDLi M, Chen Y, Chu M, Zhang S, Yang S, Lip GYH, Chen M. Village Doctor-Led Telemedicine for Rural Patients Aged 75 Years and Older With AF: A Prespecified Secondary Analysis of the MIRACLE-AF Trial. JAMA Netw Open. 2026 Mar 2;9(3):e261385. doi: 10.1001/jamanetworkopen.2026.1385.
PMID: 41817526BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2026
First Posted
March 25, 2026
Study Start (Estimated)
August 1, 2026
Primary Completion (Estimated)
December 30, 2029
Study Completion (Estimated)
December 30, 2029
Last Updated
July 28, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share